Syngen Biotech Co.,Ltd. (TPEX:8279)

Market Cap	3.51B
Revenue (ttm)	2.12B
Net Income (ttm)	279.44M
Shares Out	27.10M
EPS (ttm)	10.29
PE Ratio	12.59
Forward PE	n/a
Dividend	5.00 (3.86%)
Ex-Dividend Date	Jun 26, 2025

Volume	113,793
Average Volume	37,768
Open	129.00
Previous Close	126.50
Day's Range	129.00 - 134.00
52-Week Range	100.00 - 148.00
Beta	0.08
RSI	69.68
Earnings Date	Oct 28, 2025

About Syngen Biotech

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies; science-based and bio active pharmaceutical ingredient...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 247
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 8279

Financial Performance

In 2024, Syngen Biotech's revenue was 2.01 billion, an increase of 9.60% compared to the previous year's 1.84 billion. Earnings were 240.21 million, a decrease of -12.60%.